Skip to main content
. 2019 Oct 7;7:e7816. doi: 10.7717/peerj.7816

Table 1. Clinical characteristics of the included patients.

Characteristics Number of sample size (%)
Age (years)
≥60 203 (54.42)
<60 169 (45.31)
NA 1 (0.27)
Gender
Female 121 (32.44)
Male 252 (67.56)
Family history
Yes 112 (30.03)
No 209 (56.03)
NA 52 (13.94)
Tumor status
With tumor 112 (30.03)
Tumor free 234 (62.73)
NA 27 (7.24)
Radiation therapy
No 341 (91.42)
Yes 9 (2.41)
NA 23 (6.17)
Histologic grade
Grade 1 55 (14.75)
Grade 2 178 (47.72)
Grade 3 123 (32.98)
Grade 4 12 (3.22)
NA 5 (1.34)
Vascular invasion
Macro 16 (4.29)
Micro 94 (25.20)
None 207 (55.50)
NA 56 (15.01)
TNM Stage
Stage I 172 (46.11)
Stage II 87 (23.32)
Stage III 85 (22.79)
Stage IV 5 (1.34)
NA 24 (6.43)
T classification
T1 182 (48.79)
T2 95 (25.47)
T3 80 (21.45)
T4 13 (3.49)
TX 1 (0.27)
NA 2 (0.54)
N classification
N0 253 (67.83)
N1 4 (1.07)
NX 115 (30.83)
NA 1 (0.27)
M classification
M0 267 (71.58)
M1 4 (1.07)
MX 102 (27.35)
Residual tumor
R0 326 (87.40)
R1 17 (4.56)
R2 1 (0.27)
RX 22 (5.90)
NA 7 (1.88)
Vital status
Living 243 (65.15)
Deceased 130 (34.85)
Relapse
Yes 176 (47.18)
No 146 (39.14)
NA 51 (13.67)

Notes.

NA
not available
T
tumor stage
N
node
M
metastasis